Tags

Type your tag names separated by a space and hit enter

Validation study of the SCREENIVF: an instrument to screen women or men on risk for emotional maladjustment before the start of a fertility treatment.
Fertil Steril. 2017 06; 107(6):1370-1379.e5.FS

Abstract

OBJECTIVE

To examine construct and criterion validity of the Dutch SCREENIVF among women and men undergoing a fertility treatment.

DESIGN

A prospective longitudinal study nested in a randomized controlled trial.

SETTING

University hospital.

PATIENT(S)

Couples, 468 women and 383 men, undergoing an IVF/intracytoplasmic sperm injection (ICSI) treatment in a fertility clinic, completed the SCREENIVF.

MAIN OUTCOME MEASURE(S)

Construct and criteria validity of the SCREENIVF.

RESULT(S)

The comparative fit index and root mean square error of approximation for women and men show a good fit of the factor model. Across time, the sensitivity for Hospital Anxiety and Depression Scale subscale in women ranged from 61%-98%, specificity 53%-65%, predictive value of a positive test (PVP) 13%-56%, predictive value of a negative test (PVN) 70%-99%. The sensitivity scores for men ranged from 38%-100%, specificity 71%-75%, PVP 9%-27%, PVN 92%-100%. A prediction model revealed that for women 68.7% of the variance in the Hospital Anxiety and Depression Scale on time 1 and 42.5% at time 2 and 38.9% at time 3 was explained by the predictors, the sum score scales of the SCREENIVF. For men, 58.1% of the variance in the Hospital Anxiety and Depression Scale on time 1 and 46.5% at time 2 and 37.3% at time 3 was explained by the predictors, the sum score scales of the SCREENIVF.

CONCLUSION(S)

The SCREENIVF has good construct validity but the concurrent validity is better than the predictive validity. SCREENIVF will be most effectively used in fertility clinics at the start of treatment and should not be used as a predictive tool.

Authors+Show Affiliations

Department of Reproductive Medicine and Gynaecology, University Medical Centre Utrecht, Utrecht, the Netherlands. Electronic address: h.d.l.ockhuysen@umcutrecht.nl.Julius Centre for Health Science and primary care, University Medical Centre Utrecht, Utrecht, the Netherlands.Department of Neonatology, Wilhelmina Children's Hospital, University Medical Centre Utrecht, Utrecht, the Netherlands.School of Psychology, Cardiff University, Cardiff, United Kingdom.

Pub Type(s)

Journal Article
Randomized Controlled Trial
Validation Study

Language

eng

PubMed ID

28501369

Citation

Ockhuijsen, Henrietta D L., et al. "Validation Study of the SCREENIVF: an Instrument to Screen Women or Men On Risk for Emotional Maladjustment Before the Start of a Fertility Treatment." Fertility and Sterility, vol. 107, no. 6, 2017, pp. 1370-1379.e5.
Ockhuijsen HDL, van Smeden M, van den Hoogen A, et al. Validation study of the SCREENIVF: an instrument to screen women or men on risk for emotional maladjustment before the start of a fertility treatment. Fertil Steril. 2017;107(6):1370-1379.e5.
Ockhuijsen, H. D. L., van Smeden, M., van den Hoogen, A., & Boivin, J. (2017). Validation study of the SCREENIVF: an instrument to screen women or men on risk for emotional maladjustment before the start of a fertility treatment. Fertility and Sterility, 107(6), 1370-e5. https://doi.org/10.1016/j.fertnstert.2017.04.008
Ockhuijsen HDL, et al. Validation Study of the SCREENIVF: an Instrument to Screen Women or Men On Risk for Emotional Maladjustment Before the Start of a Fertility Treatment. Fertil Steril. 2017;107(6):1370-1379.e5. PubMed PMID: 28501369.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Validation study of the SCREENIVF: an instrument to screen women or men on risk for emotional maladjustment before the start of a fertility treatment. AU - Ockhuijsen,Henrietta D L, AU - van Smeden,Maarten, AU - van den Hoogen,Agnes, AU - Boivin,Jacky, Y1 - 2017/05/10/ PY - 2017/01/24/received PY - 2017/04/13/revised PY - 2017/04/13/accepted PY - 2017/5/16/pubmed PY - 2017/8/19/medline PY - 2017/5/15/entrez KW - Screening KW - assisted reproductive techniques KW - infertility KW - psychology KW - validation studies SP - 1370 EP - 1379.e5 JF - Fertility and sterility JO - Fertil Steril VL - 107 IS - 6 N2 - OBJECTIVE: To examine construct and criterion validity of the Dutch SCREENIVF among women and men undergoing a fertility treatment. DESIGN: A prospective longitudinal study nested in a randomized controlled trial. SETTING: University hospital. PATIENT(S): Couples, 468 women and 383 men, undergoing an IVF/intracytoplasmic sperm injection (ICSI) treatment in a fertility clinic, completed the SCREENIVF. MAIN OUTCOME MEASURE(S): Construct and criteria validity of the SCREENIVF. RESULT(S): The comparative fit index and root mean square error of approximation for women and men show a good fit of the factor model. Across time, the sensitivity for Hospital Anxiety and Depression Scale subscale in women ranged from 61%-98%, specificity 53%-65%, predictive value of a positive test (PVP) 13%-56%, predictive value of a negative test (PVN) 70%-99%. The sensitivity scores for men ranged from 38%-100%, specificity 71%-75%, PVP 9%-27%, PVN 92%-100%. A prediction model revealed that for women 68.7% of the variance in the Hospital Anxiety and Depression Scale on time 1 and 42.5% at time 2 and 38.9% at time 3 was explained by the predictors, the sum score scales of the SCREENIVF. For men, 58.1% of the variance in the Hospital Anxiety and Depression Scale on time 1 and 46.5% at time 2 and 37.3% at time 3 was explained by the predictors, the sum score scales of the SCREENIVF. CONCLUSION(S): The SCREENIVF has good construct validity but the concurrent validity is better than the predictive validity. SCREENIVF will be most effectively used in fertility clinics at the start of treatment and should not be used as a predictive tool. SN - 1556-5653 UR - https://www.unboundmedicine.com/medline/citation/28501369/Validation_study_of_the_SCREENIVF:_an_instrument_to_screen_women_or_men_on_risk_for_emotional_maladjustment_before_the_start_of_a_fertility_treatment_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S0015-0282(17)30312-6 DB - PRIME DP - Unbound Medicine ER -